Sands Capital Management
DXCM icon

Sands Capital Management’s DexCom DXCM Stock Holding History

Sands Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,934,189
Closed -$332M – 67
2025
Q3 		$332M Sell
4,934,189
-5,013,755
-50% -$397M 0.92% 32
2025
Q2 		$868M Sell
9,947,944
-466,212
-4% -$36.5M 2.49% 16
2025
Q1 		$711M Sell
10,414,156
-695,345
-6% -$56.7M 2.42% 17
2024
Q4 		$864M Buy
11,109,501
+790,303
+8% +$58.5M 2.56% 15
2024
Q3 		$692M Sell
10,319,198
-287,305
-3% -$23.6M 2.1% 18
2024
Q2 		$1.2B Sell
10,606,503
-290,261
-3% -$36.7M 3.53% 8
2024
Q1 		$1.51B Sell
10,896,764
-4,162,042
-28% -$523M 4.23% 5
2023
Q4 		$1.87B Buy
15,058,806
+1,398,136
+10% +$143M 5.68% 2
2023
Q3 		$1.27B Buy
13,660,670
+557,543
+4% +$62.8M 4.34% 6
2023
Q2 		$1.68B Sell
13,103,127
-635,841
-5% -$76.9M 5.23% 3
2023
Q1 		$1.6B Sell
13,738,968
-1,775,467
-11% -$199M 5.26% 2
2022
Q4 		$1.76B Sell
15,514,435
-1,178,883
-7% -$129M 6.64% 2
2022
Q3 		$1.34B Sell
16,693,318
-1,208,895
-7% -$102M 5.05% 3
2022
Q2 		$1.33B Buy
17,902,213
+1,145,233
+7% +$105M 4.62% 4
2022
Q1 		$2.14B Buy
16,756,980
+4,242,620
+34% +$464M 4.93% 4
2021
Q4 		$1.68B Sell
12,514,360
-783,112
-6% -$113M 3.12% 10
2021
Q3 		$1.82B Buy
13,297,472
+1,148,368
+9% +$145M 3.03% 11
2021
Q2 		$1.3B Buy
12,149,104
+403,096
+3% +$38.7M 2.2% 17
2021
Q1 		$1.06B Buy
11,746,008
+2,582,272
+28% +$242M 2.04% 20
2020
Q4 		$847M Sell
9,163,736
-162,896
-2% -$14.5M 1.61% 23
2020
Q3 		$961M Buy
9,326,632
+1,963,968
+27% +$205M 2.08% 15
2020
Q2 		$746M Buy
7,362,664
+5,371,984
+270% +$481M 1.81% 20
2020
Q1 		$134M Buy
+1,990,680
New +$124M 0.45% 45

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management's DXCM Position: Q4 2025 in Review

Sands Capital Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,934,189 shares — an estimated $332M sold.

Sands Capital Management first reported a position in DXCM in Q1 2020 and held it in 23 quarters. The position peaked at $2.14B in Q1 2022. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Sands Capital Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Sands Capital Management sold 4,934,189 DexCom shares in Q4 2025, an estimated $332M.
  • Sands Capital Management first reported a position in DexCom in Q1 2020 and held it in 23 quarters.
  • Sands Capital Management's DexCom position peaked at $2.14B in Q1 2022.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Sands Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.